MUMBAI, India, March 31, 2021 /PRNewswire/ -- Piramal Pharma Limited's (PPL) Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS), announced today that PPL ...

Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through ...

Piramal Pharma Ltd, Anant Raj Ltd, TCI Express Ltd and Avadh Sugar & Energy Ltd will turn ex-date for dividends on Wednesday.

-Piramal Pharma Ltd. continúa invirtiendo en EE.UU.; 90 millones de dólares en la expansión de dos plantas en EE.UU. Adición de capacidades de producción de inyectables estériles a escala ...

The eight stocks with July 16 as record date are TCS, Anant Raj, Piramal Pharma, Ultramarine and Pigments, Avadh Sugar, B&A ...

Piramal Pharma has committed to reduce its GHG emissions for Scope 1, 2, and 3 by 2030. MUMBAI, India, Sept. 16, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a ...

MUMBAI, India, May 14, 2025 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness c. Tuesday, 02 January 2024 12:17 GMT.

MUMBAI, India, May 24, 2023 /CNW/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the fourth quarter (Q4) and full year FY23 ended 31 st ...

MUMBAI, India, July 26, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated ...

MUMBAI, India, Oct. 23, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced its standalone and ...

Piramal Pharma Ltd. expects new molecule development and an $80 million expansion of its sterile injectable facility in Kentucky to underpin its goal of doubling revenues in the next five years, ...

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated results for the First Quarter (Q1) ended 30th June ...